Recurrence of Primary Superficial Bladder Cancer Treated with Prophylactic Intravesical Tokyo 172 Bacillus Calmette-Guerin: A Long-Term Follow-up-Reference-Cited by-同舟云学术

Recurrence of Primary Superficial Bladder Cancer Treated with Prophylactic Intravesical Tokyo 172 Bacillus Calmette-Guerin: A Long-Term Follow-up

Published:1997-03 Issue:2 Volume:4 Page:139-143
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Shinka Toshiaki,Matsumoto Miyo,Ogura Hideaki,Hirano Atsuyuki,Ohkawa Tadashi

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.1997.tb00160.x/fullpdf

Reference16 articles.

1. Intravesical Bacillus Calmette-Guérin Treatment for Superficial Bladder Tumours

2. Clinical Study of Prognostic Factors of Superficial Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin

3. Experience with intravesical bacillus calmette-guèrin therapy of superficial bladder tumors

4. Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

5. 5. DL Lamm, APM Meijden, H Akaza, ChB Brendler, PO Hedlund, Y Mizutani, TL Ratliff, MRG Robinson, and T. Shinka Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and use? The 4th Consensus on Bladder Cancer. Antwerp, Belgium, 1993 .

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis;Cancers;2023-03-23

2. Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis;European Urology Focus;2018-12

3. The Impact of Age and Clinical Factors in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette Guerin Therapy;Ultrastructural Pathology;2013-05

4. Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy;Ultrastructural Pathology;2012-10

5. Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin;European Urology;2012-07